Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 01, 2022

SELL
$2.39 - $6.02 $13,505 - $34,019
-5,651 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$5.36 - $7.99 $219 - $327
41 Added 0.73%
5,651 $31,000
Q2 2021

Jul 30, 2021

BUY
$5.82 - $8.72 $582 - $872
100 Added 1.81%
5,610 $42,000
Q1 2021

May 03, 2021

BUY
$7.2 - $16.82 $39,672 - $92,678
5,510 New
5,510 $45,000

About Kaleido Biosciences, Inc.


  • Ticker KLDO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,622,600
  • Description
  • Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...
More about KLDO
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.